VOLASTRA THERAPEUTICS, INC.

Profile

Company Names

VOLASTRA THERAPEUTICS, INC.

Addresses

1361 AMSTERDAM AVENUE, SUITE 520, NEW YORK, NY 10027

Phone Numbers

646-344-1248

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$105,274,995.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-09-08 
$30,099,998.00 
$30,099,998.00 
$0.00 
Equity 
2
2024-05-17 
$15,000,000.00 
$15,000,000.00 
$0.00 
Equity 
1
2023-03-03 
$60,174,997.00 
$60,174,997.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SAMUEL 
 
BAKHOUM 
DIRECTOR
VOLASTRA THERAPEUTICS, INC.
ARJUN 
 
BALAR 
DIRECTOR
VOLASTRA THERAPEUTICS, INC.
LUC 
 
DOCHEZ 
DIRECTOR
PROSENSA HOLDING N.V.   |  ERYTECH PHARMA S.A.   |  QURALIS CORP   |  SUMMATION BIO, INC.   |  VOLASTRA THERAPEUTICS, INC.
SCOTT 
 
DRUTMAN 
EXECUTIVE OFFICER
VOLASTRA THERAPEUTICS, INC.
JILL 
 
GOLDSTEIN 
DIRECTOR
VOLASTRA THERAPEUTICS, INC.
REZ 
 
HALZE 
DIRECTOR
VOLASTRA THERAPEUTICS, INC.
CHARLES 
 
HUGH-JONES 
EXECUTIVE OFFICER, DIRECTOR
VOLASTRA THERAPEUTICS, INC.
EILEEN 
 
MCGUIRE 
DIRECTOR
SATELLITE BIOSCIENCES, INC.   |  VOLASTRA THERAPEUTICS, INC.
ELLIE 
 
MCGUIRE 
DIRECTOR
MELLITUS, LLC   |  SATELLITE BIOSCIENCES, INC.   |  VOLASTRA THERAPEUTICS, INC.
ROBERT 
 
MITTENDORFF 
DIRECTOR
SILK ROAD MEDICAL INC   |  IMPEL NEUROPHARMA INC   |  NEOCIS, INC.   |  AVALYN PHARMA INC.   |  AKTANA, INC.   |  CAPITAL RX, INC.   |  CARLSMED, INC.   |  NALU MEDICAL, INC.   |  ATOMWISE INC.   |  VOLASTRA THERAPEUTICS, INC.   |  SOLVE THERAPEUTICS, INC.   |  NUMERION LABS, INC.
DAVID 
 
NICHOLSON 
DIRECTOR
ACTINIUM PHARMACEUTICALS, INC.   |  ACTINIUM PHARMACEUTICALS, INC.   |  LA MEND, INC.   |  BABOON MEGA CORP, INC.   |  VOLASTRA THERAPEUTICS, INC.   |  RAPALOGIX HEALTH, INC.
SANDRA 
 
PETERSON 
EXECUTIVE OFFICER, DIRECTOR
M2GEN HOLDINGS, L.P.   |  VOLASTRA THERAPEUTICS, INC.
AMY 
 
SCHULMAN 
DIRECTOR
ARSANIS, INC.   |  SUONO BIO, INC.   |  QUENTIS THERAPEUTICS, INC.   |  GLYMPSE BIO, INC.   |  CYCLERION THERAPEUTICS, INC.   |  CARDURION PHARMACEUTICALS, INC.   |  FRACTYL LABORATORIES INC.   |  AMAGMA, INC.   |  BYHEART, INC.   |  QURALIS CORP   |  FRACTYL HEALTH, INC.   |  LYNDRA THERAPEUTICS, INC.   |  THIRTY MADISON, INC.   |  VOLASTRA THERAPEUTICS, INC.   |  POLARIS PARTNERS X, L.P.   |  SEQUELAE, INC.   |  NOETIK INC.
RACHEL 
ZOLOT 
SCHWARTZ 
EXECUTIVE OFFICER
VOLASTRA THERAPEUTICS, INC.
DAVID 
 
SOUTHWELL 
EXECUTIVE OFFICER, DIRECTOR
TSCAN THERAPEUTICS, INC.   |  SENSORIUM THERAPEUTICS, INC.   |  VOLASTRA THERAPEUTICS, INC.
MICHAEL 
 
SU 
EXECUTIVE OFFICER
VOLASTRA THERAPEUTICS, INC.
DIANE 
 
TAGER 
EXECUTIVE OFFICER
VOLASTRA THERAPEUTICS, INC.
STEFAN 
 
VITOROVIC 
DIRECTOR
VIDA VENTURES, LLC   |  VVAG SPECIAL FUND LLC   |  PRAXIS PRECISION MEDICINES, INC.   |  VIDA VENTURES II, LLC   |  VIDA VENTURES II-A, LLC   |  TECTONIC THERAPEUTIC, INC.   |  VIGIL NEUROSCIENCE, INC.   |  VOLASTRA THERAPEUTICS, INC.   |  TECTONIC THERAPEUTIC, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-09-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2025-09-08 
2024-05-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-05-17 
2023-03-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-03-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#